6
results
for author:"Cahill D.P."
in Literature Citations
| MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance. Yip S., Miao J., Cahill D.P., Iafrate A.J., Aldape K., Nutt C.L., Louis D.N. Clin. Cancer Res. 15:4622-4629(2009) · Mapped (6) |
| MSH6 inactivation and emergent temozolomide resistance in human glioblastomas. Cahill D.P., Codd P.J., Batchelor T.T., Curry W.T., Louis D.N. Clin Neurosurg 55:165-171(2008) · Mapped (6) |
| Patterns of somatic mutation in human cancer genomes. Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C. et al. Nature 446:153-158(2007) · UniProtKB (453) |
| Three classes of genes mutated in colorectal cancers with chromosomal instability. Wang Z., Cummins J.M., Shen D., Cahill D.P., Jallepalli P.V., Wang T.-L., Parsons D.W., Traverso G., Awad M., Silliman N. et al. |
| Characterization of MAD2B and other mitotic spindle checkpoint genes. Cahill D.P., da Costa L.T., Carson-Walter E.B., Kinzler K.W., Vogelstein B., Lengauer C. |
| Mutations of mitotic checkpoint genes in human cancers. Cahill D.P., Lengauer C., Yu J., Riggins G.J., Willson J.K.V., Markowitz S.D., Kinzler K.W., Vogelstein B. |
